The Potency of a KRAS Silent Variant

N Engl J Med. 2022 Jun 30;386(26):2523-2525. doi: 10.1056/NEJMcibr2202981.
No abstract available

MeSH terms

  • Genetic Variation / genetics
  • Humans
  • Mutation
  • Proto-Oncogene Proteins p21(ras)* / genetics
  • Proto-Oncogene Proteins p21(ras)* / pharmacology
  • ras Proteins / genetics
  • ras Proteins / pharmacology

Substances

  • KRAS protein, human
  • Proto-Oncogene Proteins p21(ras)
  • ras Proteins